Bayer nears glyphosate settlement after lengthy talks - sources

(Reuters) - Germany's Bayer is set to reach a settlement this week with U.S. plaintiffs that claim its glyphosate-based weedkillers cause cancer, two people familiar with the matter told Reuters.After more than a year of talks, however, some details and the overall amount of the settlement have yet to be finalised, one of the sources said on condition of anonymity.German business daily Handelsblatt earlier on Tuesday reported a deal was imminent, with Bayer pledging $8-$10 billion (£6.4-8..